Literature DB >> 18938201

High-titer production of monomeric hydroxyvalerates from levulinic acid in Pseudomonas putida.

Collin H Martin1, Kristala L Jones Prather.   

Abstract

Hydroxyacids represent an important class of compounds that see application in the production of polyesters, biodegradable plastics and antibiotics, and that serve as useful chiral synthetic building blocks for other fine chemicals and pharmaceuticals. An economical, high-titer method for the production of 4-hydroxyvalerate (4HV) and 3-hydroxyvalerate (3HV) from the inexpensive and renewable carbon source levulinic acid was developed. These hydroxyvalerates were produced by periodically feeding levulinate to Pseudomonas putida KT2440 expressing a recombinant thioesterase II (tesB) gene from Escherichia coli K12. The titer of 4HV in shake flask culture reached 13.9+/-1.2 g L(-1) from P. putida tesB(+) cultured at 32 degrees C in LB medium periodically supplemented with glucose and levulinate. The highest 3HV titer obtained was 5.3+/-0.1 g L(-1) in M9 minimal medium supplemented with glucose and levulinate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938201     DOI: 10.1016/j.jbiotec.2008.09.002

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  11 in total

1.  Growth-coupled bioconversion of levulinic acid to butanone.

Authors:  Christopher R Mehrer; Jacqueline M Rand; Matthew R Incha; Taylor B Cook; Benginur Demir; Ali Hussain Motagamwala; Daniel Kim; James A Dumesic; Brian F Pfleger
Journal:  Metab Eng       Date:  2019-06-19       Impact factor: 9.783

2.  Synthetic biology strategies for synthesizing polyhydroxyalkanoates from unrelated carbon sources.

Authors:  Daniel E Agnew; Brian F Pfleger
Journal:  Chem Eng Sci       Date:  2012-12-19       Impact factor: 4.889

Review 3.  Enatiomerically pure hydroxycarboxylic acids: current approaches and future perspectives.

Authors:  Qun Ren; Katinka Ruth; Linda Thöny-Meyer; Manfred Zinn
Journal:  Appl Microbiol Biotechnol       Date:  2010-06       Impact factor: 4.813

4.  Integrated bioprocessing for the pH-dependent production of 4-valerolactone from levulinate in Pseudomonas putida KT2440.

Authors:  Collin H Martin; Danyi Wu; Kristala L Jones Prather
Journal:  Appl Environ Microbiol       Date:  2009-11-13       Impact factor: 4.792

5.  Synthetic biology for fibres, adhesives and active camouflage materials in protection and aerospace.

Authors:  Aled D Roberts; William Finnigan; Emmanuel Wolde-Michael; Paul Kelly; Jonny J Blaker; Sam Hay; Rainer Breitling; Eriko Takano; Nigel S Scrutton
Journal:  MRS Commun       Date:  2019-04-24       Impact factor: 2.566

6.  Biosynthesis of chiral 3-hydroxyvalerate from single propionate-unrelated carbon sources in metabolically engineered E. coli.

Authors:  Hsien-Chung Tseng; Catey L Harwell; Collin H Martin; Kristala L J Prather
Journal:  Microb Cell Fact       Date:  2010-11-27       Impact factor: 5.328

7.  A metabolic pathway for catabolizing levulinic acid in bacteria.

Authors:  Jacqueline M Rand; Tippapha Pisithkul; Ryan L Clark; Joshua M Thiede; Christopher R Mehrer; Daniel E Agnew; Candace E Campbell; Andrew L Markley; Morgan N Price; Jayashree Ray; Kelly M Wetmore; Yumi Suh; Adam P Arkin; Adam M Deutschbauer; Daniel Amador-Noguez; Brian F Pfleger
Journal:  Nat Microbiol       Date:  2017-09-25       Impact factor: 17.745

Review 8.  Current progress in production of biopolymeric materials based on cellulose, cellulose nanofibers, and cellulose derivatives.

Authors:  Hiba Shaghaleh; Xu Xu; Shifa Wang
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 3.361

9.  Substrate-inducible and antibiotic-free high-level 4-hydroxyvaleric acid production in engineered Escherichia coli.

Authors:  Chandran Sathesh-Prabu; Rameshwar Tiwari; Sung Kuk Lee
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09

10.  Evolution, ecology and the engineered organism: lessons for synthetic biology.

Authors:  Jeffrey M Skerker; Julius B Lucks; Adam P Arkin
Journal:  Genome Biol       Date:  2009-11-30       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.